EUVIMEDEUVIMED entdecken
Crossref

Taxifolin Inhibits Platelet Activation and Thrombosis by Regulating the PI3K/Akt and MAPK Signaling Pathways

Fang Guo, Ruping Yang, Xiuqin Xiong, Yujing Yuan, Li Zhang, Chaoying Hua, Meng Wu, Yi Xiao, Rui Zhang, Jian Liu, Zhanzhan Yang, Gang Liu iD

Molecular Nutrition & Food Research · 2025

DOI: 10.1002/mnfr.70129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Fang Guo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Quercetin, Platelet Activation, Thrombosis, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Health and Health Commission Science and Technology Fund Project, Key Projects of Xiangyang Science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive platelet activation plays a pivotal role in the development of cardiovascular disease. Taxifolin is a natural dihydroflavonol compound with antioxidant properties. However, its mechanism of action on platelets and thrombosis remains unclear. Therefore, this study aimed to investigate the effects of taxifolin on platelet function and thrombus formation and identify its potential targets. The results revealed that taxifolin inhibited platelet aggregation induced by various agonists, such as ADP, collagen, thrombin, U46619, and convulxin. Moreover, it also limited platelet adhesion to collagen and the synthesis of TXA 2 . Additionally, it impeded platelet integrin αIIbβ3 ‘’outside‐in ‘’ signaling, which is crucial for stable clot formation. In animal models, taxifolin showed promising results in preventing pulmonary embolism and arterial thrombosis. More importantly, taxifolin did not cause significant side effects. Network pharmacology analysis suggested that taxifolin may exert its effects through key targets involved in platelet aggregation and thrombus formation, such as MAPK1, AKT1, SRC, PIK3R1, and MAPK8. Meanwhile, molecular docking studies confirmed the interaction between taxifolin and MAPK1. Furthermore, taxifolin inhibited the phosphorylation of ERK, p38, JNK, and Akt, key proteins in the MAPK and PI3K/Akt signaling pathways. Overall, taxifolin demonstrated potential as an antiplatelet and antithrombotic agent, acting through multiple pathways and targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinPlatelet ActivationThrombosisProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMAP Kinase Signaling SystemAnimalsMolecular Docking SimulationPlatelet AggregationMaleHumansSignal TransductionPlatelet Aggregation InhibitorsBlood Platelets

Stichwörter der Autor:innen

PI3K/AKT signalingnetwork pharmacologyplatelettaxifolin

Substanzen

taxifolinQuercetinProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
  • Department of Pharmacy, Xiangyang Key Laboratory of Special Preparation of Vitiligo, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
  • School of Pharmacy, Guizhou Medical University, Guiyang, China.
  • School of Laboratory Animal & Shandong Laboratory Animal Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
  • Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guizhou Medical University, Guiyang, China.

ORCID-Profile: Gang Liu

Förderung

  • National Natural Science Foundation of China
  • Guizhou Health and Health Commission Science and Technology Fund Project
  • Key Projects of Xiangyang Science and Technology Plan
  • Guizhou Provincial Science and Technology Project

Zitieren

APA

Guo, F., Yang, R., Xiong, X., Yuan, Y., Zhang, L., Hua, C., Wu, M., Xiao, Y., Zhang, R., Liu, J., Yang, Z., & Liu, G. (2025). Taxifolin Inhibits Platelet Activation and Thrombosis by Regulating the PI3K/Akt and MAPK Signaling Pathways. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70129

Vancouver

Guo F, Yang R, Xiong X, Yuan Y, Zhang L, Hua C, et al. Taxifolin Inhibits Platelet Activation and Thrombosis by Regulating the PI3K/Akt and MAPK Signaling Pathways. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70129

BibTeX
@article{Guo2025,
  author = {Guo, Fang and Yang, Ruping and Xiong, Xiuqin and Yuan, Yujing and Zhang, Li and Hua, Chaoying and Wu, Meng and Xiao, Yi and Zhang, Rui and Liu, Jian and Yang, Zhanzhan and Liu, Gang},
  title = {Taxifolin Inhibits Platelet Activation and Thrombosis by Regulating the PI3K/Akt and MAPK Signaling Pathways},
  journal = {Molecular Nutrition & Food Research},
  year = {2025},
  doi = {10.1002/mnfr.70129}
}
Kostenlos starten →